Benzodiazépines, addiction et autorisation cantonale : cadre juridique et implications cliniques [Benzodiazepines, addiction and cantonal authorization : legal framework and clinical implications.]
Fiche du document
9 juin 2021
- doi: 10.53738/REVMED.2021.17.742.1115
- issn: 1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.53738/REVMED.2021.17.742.1115
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/34106536
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1660-9379
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_812B42B72B9F8
info:eu-repo/semantics/openAccess , CC BY-NC-ND 4.0 , https://creativecommons.org/licenses/by-nc-nd/4.0/
Mots-clés
Behavior, Addictive; Benzodiazepines; Humans; Substance-Related Disorders/epidemiology; SwitzerlandSujets proches
Narcotic habit Addiction to drugs Drug dependence Drug dependency Narcotic addiction Drug habit Narcotics addiction Drug use Recreational drug use Dependent behavior Drogues Anchors, Drift Sea anchors Drift anchors Adicción a las drogas Consumo de drogas Dependencia de las drogas Drogadicción Drogodependencia Dependencia psicológica Abuso de drogas Adicción a las drogas Dependencia de las drogas Drogadicción Drogodependencia Dépendance biologique Dépendance physique Addiction Dépendance physiologique Relation de dépendance Comportement de dépendance Addiction Relations de dépendance Abus des drogues Addiction Pharmacomanie Accoutumance aux drogues PharmacodépendanceCiter ce document
V. Junod et al., « Benzodiazépines, addiction et autorisation cantonale : cadre juridique et implications cliniques [Benzodiazepines, addiction and cantonal authorization : legal framework and clinical implications.] », Serveur académique Lausannois, ID : 10.53738/REVMED.2021.17.742.1115
Métriques
Partage / Export
Résumé
Use of benzodiazepine and Z-drug is common in Switzerland, also for prolonged periods of time. Physical dependence, psychological dependence and a syndrome of dependence may ensue. Related to a lack of well-established medical guidelines, current clinical practices are subject to debate. Also controversial is the need to request an authorization from the cantonal health authorities before starting treatment with these controlled substances. The present article describes the limited circumstances in which such prior authorization is required.